A large-scale recall of infant formula is spreading worldwide. Analysts say the wave of recalls by major global formula corporations over contamination in a specific ingredient has exposed vulnerabilities in the formula supply chain.
According to Reuters, AFP and other foreign media on Jan. 9, the formula recall crisis first surfaced in December. The severity grew as three infants died in France after consuming recalled products. The French government identified arachidonic acid (ARA) oil supplied by Cabio Biotech in Wuhan as the cause.
Arachidonic acid is an omega-6 fatty acid that naturally occurs in breast milk. Formula makers process arachidonic acid into an oil to add to products in order to make formula resemble breast milk as closely as possible. But the ingredient was found to contain the toxin cereulide, which causes food poisoning such as vomiting and diarrhea. While ordinary bacteria die when heated at high temperatures, cereulide is heat-resistant and is known not to be destroyed during the high-temperature sterilization in formula manufacturing or when parents mix formula with hot water at home.
As a result, global corporations including Nestle, Danone and Lactalis carried out large-scale voluntary recalls in more than 60 countries. The European Union (EU) executive commission said in its official journal that there is a need to establish reinforced levels of official controls and special conditions regarding imports of Chinese arachidonic acid oil. It did not specify the company involved, but Chinese firm "Cabio Biotech" has reportedly been identified as the source supplier for this incident and is under investigation.
Industry officials view the incident not as a simple manufacturing-process mistake but as one that revealed the fragility of the concentrated supply chain structure built by global formula companies. In a structure with high dependence on certain ingredient suppliers, problems at one source rippled simultaneously across multiple brands and countries.
An industry official said, "Arachidonic acid has demanding production technology and facility requirements, so the number of suppliers is limited," adding, "Manufacturers have often sourced ingredients in bulk from a small number of companies for expense efficiency and quality standardization." Fewer than 10 companies worldwide are known to supply specialized ingredients such as arachidonic acid. From the perspective of formula manufacturers, they have little choice but to procure ingredients from regions where regulatory standards are relatively looser or production costs are lower to reduce expense.
Amid this situation, some European organic brands appear to have escaped the crisis. Among them, the HiPP Combiotic organic line of the German organic formula brand HiPP was excluded from the recall list and is drawing attention. While major global corporations recalled products due to contamination of Chinese arachidonic acid ingredients, HiPP used the same component but maintained an independent sourcing network within Europe, helping it avoid the crisis, according to analysts.
HiPP said it has sourced arachidonic acid oil from independent suppliers within Europe. It did not use ingredients from the supplier at the center of the controversy.
Key components such as milk and whey are also supplied mainly from Germany and neighboring EU countries. In particular, the company has direct contracts with more than 6,000 organic farms, directly managing the entire production stage. In addition to EU organic regulations, it also meets private certification standards such as Bioland and Demeter, and reduces the possibility of external ingredient admixture through supplier traceability, regional sourcing and dual certification audits.
HiPP also said it operates a multilayered quality management system from the raw material stage. A HiPP official said, "From the initial stages of cultivating the special mold used to extract arachidonic acid oil, we conduct strict monitoring," adding, "Cereulide is produced only in the presence of the causative bacterium Bacillus cereus, and because we exclude the causative bacterium before the oil extraction stage, we have secured safety to the extent that additional testing at the finished goods stage is unnecessary."
In addition, through a multi-test system—including ▲soil analysis and crop monitoring of contract farms (pre-harvest testing) ▲raw material testing upon receipt at manufacturing facilities ▲process monitoring during formulation and blending ▲final product microbiological and chemical testing before release ▲retention of storage samples for post-market surveillance—it filters out risk factors before the finished goods stage.
However, HiPP's supply chain model also has limits. Given its structure centered on organic ingredients and contract farms, it is difficult to sharply increase output in a short period. Organic farms require at least two to three years for certification conversion, and the organic ingredient market itself accounts for a small share of the overall agricultural market. As a result, an organic-centered supply chain is assessed as a structure that focuses on stable supply and quality control rather than large-scale production expansion. A HiPP official said, "HiPP's retail prices are about 15% to 30% higher than competitors', but it is not simply brand value; it reflects efforts to maintain a safe supply chain," adding, "This is a competitive edge that rivals cannot emulate in the short term during a crisis."